CClinicalTrials.gg
CompletedNCT07084636Updated Jul 24, 2025

Comparative of Video Laryngeal Mask and Endotracheal Intubation in Patients Undergoing Tympanoplasty Surgery.

An interventional study of Video Laryngeal Mask and Endotracheal intubation in Tympanoplasty Surgery and Laryngeal Mask Airway, sponsored by Samsun University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-07-24.

Sponsored by Samsun University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Dec 2024, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
98
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The effects of video laryngeal mask and endotracheal intubation on hemodynamic parameters and the development of postoperative respiratory complications in participants scheduled for tympanoplasty will be evaluated.

Read the detailed description

Procedures to be performed under general anesthesia are performed by placing endotracheal intubation and laryngeal mask in the airway. Video Laryngeal Mask (LMA) combines the upper glottic airway device with video laryngoscope tracheal intubation. LMA placement and tracheal intubation can be visualized, LMA position can be continuously monitored during the operation, and adverse events such as LMA displacement can be managed in a timely manner. Studies have shown that video LMA has extraordinary advantages in airway management. This study aimed to compare video LMA and endotracheal intubation in participants who will undergo tympanoplasty surgery.

02

Conditions studied

  • Tympanoplasty Surgery
  • Laryngeal Mask Airway

Keywords

  • tympanoplasty
  • video laryngeal mask
  • airway
  • intubation
  • general anesthesia
03

In context

Lead sponsor

Samsun University is the lead sponsor of 81 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Participants aged 18-75
  • Participants with ASA I-II-III
  • Cases with surgery duration of less than two hours

Exclusion criteria

Exclusion Criteria:

  • Participants under 18 years of age
  • Participants who are pregnant
  • Participants with a difficult airway diagnosis
  • Participants with a mouth opening of less than 4 cm
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
98 participants (actual)

Study arms

  • Active comparator
    Group Laryngeal Mask Airway

    In this group, after 3 minutes of preoxygenation, 2 mg/kg propofol will be administered intravenously. A laryngeal mask will be placed after induction, the cuf will be inflated and fixed with a cuf manometer.

    Other: Video Laryngeal Mask

  • Active comparator
    Group Endotracheal Tube

    In this group, after 3 minutes of preoxygenation, 2 mg/kg propofol will be administered intravenously, 1 mcg/kg fentanyl will be administered intravenously. Additionally, 0.6 mg/kg rocuronium will be administered intravenously and endotracheal intubation will be performed, and the cuff will be inflated and fixed with a cuff manometer.

    Other: Endotracheal intubation

Interventions

  • OtherVideo Laryngeal Mask

    Video laryngeal mask will be used in this group

  • OtherEndotracheal intubation

    Endotracheal intubation will be performed in this group.

06

What researchers measure

Primary outcomes

  1. Time to Effective Airway

    The time to achieve an effective airway was defined as the time between removing the face mask, attaching the airway device, and obtaining 3 square wave capnograph traces with manual ventilation.

    Time frame: Baseline

Secondary outcomes

  1. Number of attempts taken for successful placement of airway device

    Number of attempts needed for successful placement of either the SaCoVLM™ video laryngeal mask airway the tracheal tube, as assigned

    Time frame: Baseline

  2. Haemodynamic response to insertion of airway device

    Systolic blood pressure and heart rate at 0th minute, 1st minute 5th minute, starting from the time the face mask was removed from the patient's face.

    Time frame: Baseline, 1st minute, 5th minute

  3. Displacement of the SaCoVLM™ video laryngeal mask in head position

    Effect of Head Rotation During Tympanoplasty on laryngeal visibility with the SaCoVLM™ Laryngeal Mask during head rotation

    Time frame: Baseline

  4. Incidence of post-operative sore throat

    postoperative sore throat will be recorded at 1st hour, 6th hour, 12th hour, 18th hour, 24th hour

    Time frame: 24 hours after surgery

07

Study locations

1 site
  • Samsun University, Samsun Training and Research Hospital
    Samsun, Ilkadım 55000, Turkey (Türkiye)
08

References and documents

Publications

  • Sun Y, Huang L, Xu L, Zhang M, Guo Y, Wang Y. The Application of a SaCoVLMTM Visual Intubation Laryngeal Mask for the Management of Difficult Airways in Morbidly Obese Patients: Case Report. Front Med (Lausanne). 2021 Nov 18;8:763103. doi: 10.3389/fmed.2021.763103. eCollection 2021. PubMed 34869469 ↗
  • Yan CL, Chen Y, Sun P, Qv ZY, Zuo MZ. Preliminary evaluation of SaCoVLM video laryngeal mask airway in airway management for general anesthesia. BMC Anesthesiol. 2022 Jan 3;22(1):3. doi: 10.1186/s12871-021-01541-0. PubMed 34979936 ↗
  • Choi WJ, Kim YH. The influence of head rotation on ProSeal laryngeal mask airway sealing during paediatric myringotomy. Anaesth Intensive Care. 2007 Dec;35(6):957-60. doi: 10.1177/0310057X0703500617. PubMed 18084990 ↗

Individual participant data

Plan to share: No — The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07084636
Lead sponsor
Samsun University
Responsible party
Sponsor
First posted
Jul 24, 2025
Start date
Dec 1, 2024
Primary completion
Jul 5, 2025
Completion
Jul 17, 2025
Last update
Jul 24, 2025

Study contacts

HATİCE SELÇUK KUŞDERCİ, asst prof
study director · SAMSUN UNİVERSITY

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion